Amgen CEO gets 38% pay increase to $21M

In a year when many drug CEOs saw their pay packages decline or remain stagnant, Amgen chief Kevin Sharer (photo) got a 38 percent bump. Sharer's 2010 compensation came to $21.1 million, up from $15.3 million in 2009--a figure that far outclasses several pharma CEOs' pay packages, even at far larger companies. Report